Streetbeat News

Stock Prices

MDB

MongoDB's share price dropped after the announcement of CFO Michael Gordon's departure, despite no negative business performance. This presents a potential buying opportunity for investors looking towards 2025.

Portfolio Pulse from

December 11, 2024 | 1:30 pm

AAAU

Jim Wyckoff, a seasoned financial journalist, provides an analysis of the gold market for December 11, focusing on key intra-day price entry levels for active traders. The article may mention AAAU, a gold-related ETF.

Portfolio Pulse from

December 11, 2024 | 1:30 pm

PCRX

DOMA Perpetual Capital Management plans to nominate four independent directors at Pacira BioSciences' 2025 annual meeting, expressing belief in the company's undervalued stock and urging a stock tender offer.

Portfolio Pulse from

December 11, 2024 | 1:30 pm

PLAY

Dave & Buster's is facing challenges in capturing consumer spending, and the sudden exit of its CEO has added uncertainty to its turnaround efforts. Truist has downgraded the stock from 'buy' to 'hold', indicating concerns about the company's future performance.

Portfolio Pulse from

December 11, 2024 | 1:30 pm

OLLI

Ollie's Bargain Outlet Holdings, Inc. (OLLI) reported mixed Q3 results with earnings beating estimates but sales missing expectations. Comparable sales declined by 0.5% year-over-year, ending a nine-quarter growth streak and leading to a revised outlook.

Portfolio Pulse from

December 11, 2024 | 1:30 pm

LLY

Eli Lilly's investigational drug, Imlunestrant, shows significant improvement in progression-free survival for ER+, HER2- advanced breast cancer patients, both as monotherapy and in combination with Verzenio. The Phase 3 EMBER-3 study results were published in the New England Journal of Medicine.

Portfolio Pulse from

December 11, 2024 | 1:30 pm

USO

The article suggests that investing in crude oil may offer better returns than gold in 2025 due to cooling geopolitical tensions and a new US administration. Gold prices have struggled to break above $2,700 per ounce, making oil a more attractive investment.

Portfolio Pulse from

December 11, 2024 | 1:30 pm

PLAY

Dave & Buster's stock declined after reporting a larger-than-expected loss for Q3 and the resignation of its CEO.

Portfolio Pulse from

December 11, 2024 | 1:30 pm

ATOS

Atossa Therapeutics has announced full results from its Phase 2 KARISMA-Endoxifen study, showing that a 1 MG dose of (Z)-Endoxifen significantly reduces mammographic breast density. This suggests potential as a preventative therapy for premenopausal women at risk of breast cancer.

Portfolio Pulse from

December 11, 2024 | 1:30 pm

GMAB

Genmab A/S (Nasdaq: GMAB) is hosting its 2024 R&D Update and ASH Data Review Meeting virtually on December 11, 2024. The event will be available via live webcast.

Portfolio Pulse from

December 11, 2024 | 1:30 pm